StockStory Favors Hubbell, Flags Charles River and Verisk
The publisher points to Hubbell’s revenue growth and cash-flow gains, while questioning growth and returns at two other S&P 500 companies.
Makkler Newsroom · Oct 12, 05:57 PM · 1 min read
Charles River Laboratories International, Inc. CRL
NYSECommercial ServicesUnited States
$337.97-2.84 (-0.83%)
Market closed· · USD · Data may be delayed
- Day's range
- 333.04342.58
- 52-week range
- 146.20379.63
Financial health
– / 5
Analyst view · 19 firms
Buy14 buy · 3 hold · 2 sell
Avg. target $368.07 (+8.9%)
Prices may be delayed and are for informational purposes only - not investment advice.